Clinical efficacy of lenalidomide in patients with relapsed or refractory chronic lymphocytic leukemia: results of a phase II study
…, C Chrystal, P Starostik… - Journal of clinical …, 2006 - ascopubs.org
Purpose Patients with relapsed or refractory chronic lymphocytic leukemia (CLL) have
profound immune defects and limited treatment options. Given the dramatic activity of …
profound immune defects and limited treatment options. Given the dramatic activity of …
Acquirement of Rituximab Resistance in Lymphoma Cell Lines Is Associated with Both Global CD20 Gene and Protein Down-Regulation Regulated at the …
…, A Kotowski, A Binder, H Kaur, J Knight, P Starostik… - Clinical Cancer …, 2008 - AACR
Acquirement of resistance to rituximab has been observed in lymphoma patients. To define
mechanisms associated with rituximab resistance, we developed various rituximab-resistant …
mechanisms associated with rituximab resistance, we developed various rituximab-resistant …
Multisite Investigation of Outcomes With Implementation of CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention
…, TC Skaar, DM Smith, VB Sriramoju, P Starostik… - JACC: Cardiovascular …, 2018 - jacc.org
Objectives : This multicenter pragmatic investigation assessed outcomes following clinical
implementation of CYP2C19 genotype–guided antiplatelet therapy after percutaneous …
implementation of CYP2C19 genotype–guided antiplatelet therapy after percutaneous …
ATM Mutations in B-Cell Chronic Lymphocytic Leukemia
F Bullrich, D Rasio, S Kitada, P Starostik, T Kipps… - Cancer research, 1999 - AACR
Mutations in the ATM gene located on the long arm of chromosome 11 at 11q22–23 cause
ataxia-telangiectasia, an autosomal recessive disorder that is associated with increased …
ataxia-telangiectasia, an autosomal recessive disorder that is associated with increased …
Epstein-Barr virus–associated B-cell lymphoproliferative disorders in angioimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma, unspecified
A Zettl, SS Lee, T Rüdiger, P Starostik… - American journal of …, 2002 - academic.oup.com
Various patterns of Epstein-Barr virus (EBV)-associated B-cell lymphoproliferation occur in
patients with immunodeficiency. We studied 17 cases of T-cell lymphoma displaying …
patients with immunodeficiency. We studied 17 cases of T-cell lymphoma displaying …
Gastric marginal zone B-cell lymphomas of MALT type develop along 2 distinct pathogenetic pathways
P Starostik, J Patzner, A Greiner… - Blood, The Journal …, 2002 - ashpublications.org
Low-grade marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT)
type can transform into high-grade diffuse large B-cell lymphoma (DLBCL). Up to 60% of the …
type can transform into high-grade diffuse large B-cell lymphoma (DLBCL). Up to 60% of the …
[HTML][HTML] CYP2D6-guided opioid therapy improves pain control in CYP2D6 intermediate and poor metabolizers: a pragmatic clinical trial
…, K Newsom, A Wright, EI Rosenberg, P Starostik… - Genetics in …, 2019 - Elsevier
Purpose CYP2D6 bioactivates codeine and tramadol, with intermediate and poor metabolizers
(IMs and PMs) expected to have impaired analgesia. This pragmatic proof-of-concept trial …
(IMs and PMs) expected to have impaired analgesia. This pragmatic proof-of-concept trial …
Chromosomal gains at 9q characterize enteropathy-type T-cell lymphoma
…, G Ott, A Makulik, T Katzenberger, P Starostik… - The American journal of …, 2002 - Elsevier
Genetic alterations in enteropathy-type T-cell lymphoma (ETL) are unknown so far. In this
series, 38 cases of ETL were analyzed by comparative genomic hybridization (CGH). CGH …
series, 38 cases of ETL were analyzed by comparative genomic hybridization (CGH). CGH …
Deficiency of the ATM protein expression defines an aggressive subgroup of B-cell chronic lymphocytic leukemia
P Starostik, T Manshouri, S O'Brien, E Freireich… - Cancer research, 1998 - AACR
The gene mutated in ataxia telangiectasia, ATM, on human chromosome 11q22–q23 is
implicated in cell cycle control and DNA repair. Ataxia telangiectasia patients as well as ATM-…
implicated in cell cycle control and DNA repair. Ataxia telangiectasia patients as well as ATM-…
Co-occurring alterations in the RAS–MAPK pathway limit response to MET inhibitor treatment in MET exon 14 skipping mutation-positive lung cancer
…, RB Corcoran, I Yeh, BC Bastian, P Starostik… - Clinical Cancer …, 2020 - AACR
Purpose: Although patients with advanced-stage non–small cell lung cancers (NSCLC)
harboring MET exon 14 skipping mutations (METex14) often benefit from MET tyrosine kinase …
harboring MET exon 14 skipping mutations (METex14) often benefit from MET tyrosine kinase …
